Gilteritinib-associated hand-foot syndrome: a novel dermatologic reaction in refractory FLT3 Acute myeloid leukemia
Objective: Second generation tyrosine kinase inhibitors (TKIs) such as gilteritinib, characterized by minimal EGFR and absent VEGFR inhibition, are in theory associated with low dermatologic toxicity. This case report brings to the awareness that the opposite may occur and emphasize the need for att...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2026-01-01
|
| Serija: | Leukemia Research Reports |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2213048926000257 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|